World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia-Reference-Cited by-同舟云学术

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia

Published:2006-01 Issue:1 Volume:7 Page:5-40
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Falkai Peter,Wobrock Thomas,Lieberman Jeffrey,Glenthoj Birte,Gattaz Wagner F.,Möller Hans-Jürgen,WFSBP Task Force on Treatment Guide ,Falkai Peter,Wobrock Thomas,Lieberman Jeffrey,Glenthoj Birte,Gattaz Wagner F.,Möller Hans-Jürgen,WFSBP Task Force on Treatment Guide

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.1080/15622970500483177

Reference251 articles.

1. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

2. Double-Blind, Placebo-Controlled Comparison of the Efficacy of Sertraline as Treatment for a Major Depressive Episode in Patients With Remitted Schizophrenia

3. Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients

4. Haloperidol decanoate in chronic schizophrenia: A study of 12 months with plasma levels

5. Intramuscular Preparations of Antipsychotics

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and off-label utilization of antipsychotics in children and adolescents from 2016 to 2021 in China: a real-world study;Child and Adolescent Psychiatry and Mental Health;2024-06-21

2. A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine;Biomolecules;2023-08-23

3. Antipsychotics/Neuroleptics: Course and Duration of Therapy, Withdrawal Symptoms, Resistance to Therapy, Side Effects, and Contraindications;NeuroPsychopharmacotherapy;2022

4. Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study;European Archives of Psychiatry and Clinical Neuroscience;2021-08-22

5. Using cortical non-invasive neuromodulation as a potential preventive treatment in schizophrenia - A review;Brain Stimulation;2021-05